newsfilter
← Latest News
GlobeNewswire·

Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit

ZUG, Switzerland, October 29th, 2026 -- Oculis Holding AG (NASDAQ:OCS, XICE: OCS)) ("Oculis"), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in